The lawsuit was filed in 2017 by shareholder Chaile Steinberg against former and current McKesson executives and directors. McKesson workers’ labor union, the International Brotherhood of Teamsters, led a campaign last year to vote against the company’s executive pay plan as a result of the lawsuit.
The 10 percent trim will take about $1.95 million off Mr. Hammergren’s pay in 2018. A regulatory filing also indicates the company has changed incentive plan metrics and will consider opioid distribution compliance risk in executive compensation decisions, according to the report. Mr. Hammergren received $18.1 million total compensation in fiscal 2017, including salary, cash bonus, long-term cash payout and equity awards.
Read more here.
More articles on opioids:
Cryptomarket opioid sales increased after DEA tightened prescribing regulations
Kentucky sues Walgreens over ‘alarming’ opioid dispense rate
Viewpoint: The one step Trump should take to ease the opioid epidemic
